Great, Ted. Thank you. The Apex segment, which consists, of course, of Apex Systems, Apex Life Sciences and Creative Circle business units, again reported solid results for the quarter. Segment revenues were $567.6 million and were up 12.9% year-over-year, an acceleration from our first quarter year-over-year growth rate of 11.6%.
Apex Systems, which accounts for 75.1% of the segment's revenues, grew its revenues year-over-year by 13.4% in the second quarter. Also happy to report, our Creative Circle unit grew its revenues 10.3%, and our Life Sciences unit, including StratAcuity, which accounts for 7.8% of our segments' revenues, grew its revenues 15% on an as-reported basis.
Gross margin for the segment was in line with the prior year period, reflecting stable pricing in our end markets. Our segment's EBITDA also grew double digits as we saw efficient conversion of gross profit to EBITDA, which was mainly driven by continued strong revenue growth and productivity of our sales, delivery and infrastructure teams.
As we usually do on these calls, we give you some insights on some factors driving Apex Systems' performance, which is our principal IT services business unit. Apex Systems revenue growth was propelled by a number of factors including: continued growth in our accounts in all 7 industry verticals we service, with double-digit revenue growth in 4 of the 7 industry verticals, including financial services, health care, consumer industrial and technology industry accounts.
Of the remaining 3 industry verticals, aerospace/defense, business services, they both grew high single digits; and the 7th industry, telecommunication accounts, exhibited positive mid-single-digit growth year-over-year. Growth was also achieved in both our top accounts and retail or branch-centric accounts with top accounts growing double digits and outpacing our overall revenue growth. Retail accounts also posted mid-single digit revenue growth rates.
Our bookings for consulting-type work continue to remain strong in the quarter and, and it has been reported in previous quarters, continue to significantly exceed our expectations for growth.
And finally, as previously mentioned, our focus on field and back-office productivity and the tools they use also continue to improve during the quarter which supported our EBITDA performance.
Creative Circle's revenue and profitability growth in the quarter exceeded our initial expectations as I implied. The end market for creative marketing remains positive, and we continue to see more growth in corporate business as our accounts are shifting more work internally versus using ad agencies for support. This trend is a positive for the use of our services by our customer base.
Our Life Sciences business revenue growth was also double digits on an as-reported basis, and as I suggested, exceeded our expectations for both revenue growth and EBITDA margins.
Overall, the Apex segment had yet another very solid quarter and continues to significantly outpace the growth rate of the overall industry.
George, turn it over to you.